Securing and maintaining patent rights involves navigating a complex and administratively burdensome system.

Your patent attorney will guide you through the process but patent applicants also have a part to play to ensure that all runs smoothly. The patents system is deadline driven and missing certain deadlines can have a catastrophic effect on your patent rights.

In this session Vanessa Stainthorpe will use case studies to help recognise risky practices in portfolio management and outline what can be done when something goes wrong. We will explain the circumstances in which patent applications can (and can’t) be restored, for example using the European Patent Office’s further processing and reinstatement procedures, discuss recent case law decisions and give practical advice on how to avoid losing your valuable patent rights.

You may also like

Plausibility, polymorphs and purity

25th February

Plausibility, polymorphs and purity have been recurring themes in the EPO’s Board of Appeal decisions. These topics can underpin a pharmaceutical company’s filing and life cycle management strategy. The EPO’s decisions have been mixed and, in the last year, the Boards have yet again pronounced on these topics in a number of decisions. We will review and discuss the key features of these decisions.

Careful crafting and compliant claims; Advertising Standards Authority regulation in the health sector

23rd February

This session will examine the provisions of the Advertising Standards Authority codes which relate to the health sector. We will consider a number of recent decisions in this area and offer practical advice on how to ensure advertising for those operating in the healthcare sector is compliant with the ASA’s codes.

Motivating big pharma to embrace emerging technology: it’s not always about the small molecule

Tuesday 2nd March

The discussion will look at the advantages and disadvantages of engaging with Big Pharma, and then look at what can attract Big Pharma to new territories. Our conclusions will be used to reflect broadly on what this may mean for the microbiome field.